Celesta Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Auradine develops ultra-low-power compute technology for AI applications across cloud data centers, edge, and physical/embodied AI.
AI & Machine LearningHardwareSemiconductorsCampbell, US
Barun Kar(Executive Officer, Director)in
BoardRajiv Khemani(Director)inNavin Chaddha(Director)inFred Thiel(Director)inSaid Ouissal(Director)
Board seatSriram Viswanathan· per SEC Form D · $73.7M raise · filed May 2022
Co-investorsCleo CapitalAIspace VenturesCapricorn Investment GroupCota CapitalDCVC (Data Collective)Maverick Capital+10 more
Prellis Biologics runs an antibody discovery platform that uses two-photon laser-bioprinted human immune organoids combined with machine learning to identify fully human antibody therapeutics.
AI & Machine LearningBiotechDeep TechHayward, US
Melanie Matheu(Executive Officer, Director)Noelle Mullin(Executive Officer, Director)
BoardArvind Gupta(Director)Rohit Sharma(Director)in
Board seatMichael Marks· per SEC Form D · $35M raise · filed Jul 2022
Co-investorsBlack Diamond VenturesCivilization Ventures Management, LlcOpen Field CapitalPrefix CapitalCantos VenturesKhosla Ventures+2 more
Normal Computing develops software and hardware infrastructure optimizing AI models for physical systems through custom silicon design and advanced EDA tools.
AI & Machine LearningHardwareSemiconductorsSan Francisco, US
Faris Sbahi(Executive Officer, Director)inAntonio Martinez(Founder)inMatthias Tan(Founder)inAaron Sisto(Director)Yui-Hong Matthias Tan(Executive Officer, Director)
Co-investorsDrive CapitalSamsung Catalyst FundSamsung NextFirst Spark Ventures, LlcMicron Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.